Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The therapeutic potential of purinergic signalling
Geoffrey Burnstock
Biochemical Pharmacology (2017) Vol. 151, pp. 157-165
Closed Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
Luca Antonioli, Corrado Blandizzi, Pál Pacher, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 345-382
Open Access | Times Cited: 136
Molecular Mechanisms of Microglial Motility: Changes in Ageing and Alzheimer’s Disease
Diana Franco-Bocanegra, Ciaran McAuley, James A. R. Nicoll, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 639-639
Open Access | Times Cited: 114
Molecular pharmacology of P2Y receptor subtypes
Ivar von Kügelgen
Biochemical Pharmacology (2020) Vol. 187, pp. 114361-114361
Closed Access | Times Cited: 74
Contribution of P2X4 Receptors to CNS Function and Pathophysiology
Alejandro Montilla, Gilda Paloma Mata, Carlos Matute, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5562-5562
Open Access | Times Cited: 64
Alzheimer’s disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation
Shehata Anwar, Serge Rivest
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 4, pp. 331-344
Closed Access | Times Cited: 56
Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications
Hamideh Zarrinmayeh, Paul R. Territo
Molecular Imaging (2020) Vol. 19
Open Access | Times Cited: 54
Purinergic modulation of the immune response to infections
Natalia Eberhardt, Gastón Bergero, Yanina L. Mazzocco Mariotta, et al.
Purinergic Signalling (2022) Vol. 18, Iss. 1, pp. 93-113
Open Access | Times Cited: 28
P2X3 receptor antagonism attenuates the progression of heart failure
Renata Maria Lataro, Davi J. A. Moraes, Fábio Nelson Gava, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Amelioration of Alcoholic Liver Steatosis by Dihydroquercetin through the Modulation of AMPK-Dependent Lipogenesis Mediated by P2X7R–NLRP3-Inflammasome Activation
Yu Zhang, Quan Jin, Xia Li, et al.
Journal of Agricultural and Food Chemistry (2018) Vol. 66, Iss. 19, pp. 4862-4871
Closed Access | Times Cited: 55
Antithrombotic P2Y12 receptor antagonists: recent developments in drug discovery
Younis Baqi, Christa E. Müller
Drug Discovery Today (2018) Vol. 24, Iss. 1, pp. 325-333
Closed Access | Times Cited: 52
P2X receptors and acupuncture analgesia
Yong Tang, Haiyan Yin, Juan Liu, et al.
Brain Research Bulletin (2018) Vol. 151, pp. 144-152
Open Access | Times Cited: 48
Energy metabolism disorders and potential therapeutic drugs in heart failure
Yanan He, Wei Huang, Chen Zhang, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 5, pp. 1098-1116
Open Access | Times Cited: 46
Cardiac Connexin-43 Hemichannels and Pannexin1 Channels: Provocative Antiarrhythmic Targets
Katarína Andelová, Tamara Egan Beňová, Barbara Szeiffová Bačová, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 260-260
Open Access | Times Cited: 44
Recommended tool compounds and drugs for blocking P2X and P2Y receptors
Christa E. Müller, Vigneshwaran Namasivayam
Purinergic Signalling (2021) Vol. 17, Iss. 4, pp. 633-648
Open Access | Times Cited: 36
Thalamus: The ‘promoter’ of endogenous modulation of pain and potential therapeutic target in pathological pain
Hao‐Jun You, Jing Lei, Antti Pertovaara
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104745-104745
Closed Access | Times Cited: 26
ATP-mediated signalling in the central synapses
Ulyana Lalo, Yuriy Pankratov
Neuropharmacology (2023) Vol. 229, pp. 109477-109477
Open Access | Times Cited: 13
Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy
Ágatha Oliveira‐Giacomelli, Yahaira Naaldijk, Laura Sardà‐Arroyo, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 44
Metabolic features of Gulf War illness
Robert K. Naviaux, Jane C. Naviaux, Kefeng Li, et al.
PLoS ONE (2019) Vol. 14, Iss. 7, pp. e0219531-e0219531
Open Access | Times Cited: 37
Adenosine kinase: A key regulator of purinergic physiology
Detlev Boison, Michael F. Jarvis
Biochemical Pharmacology (2020) Vol. 187, pp. 114321-114321
Open Access | Times Cited: 35
The potential involvement of P2X7 receptor in COVID‐19 pathogenesis: A new therapeutic target?
Paulo Pacheco, Robson Xavier Faria
Scandinavian Journal of Immunology (2020) Vol. 93, Iss. 2
Open Access | Times Cited: 34
To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?
Leanne Stokes, Stefan Bidula, Lučka Bibič, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 33
Therapeutic Targeting of P2X Receptors for Orofacial Pain
Jing Zhang, Tianjuan Ju, Yaru Qin, et al.
Brain Research Bulletin (2025), pp. 111301-111301
Open Access
Therapeutic potential of adenosine kinase inhibition—Revisited
Michael F. Jarvis
Pharmacology Research & Perspectives (2019) Vol. 7, Iss. 4
Open Access | Times Cited: 32
Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism
Mauro Mozael Hirsch, Iohanna Deckmann, Júlio Santos‐Terra, et al.
Neuropharmacology (2020) Vol. 167, pp. 107930-107930
Open Access | Times Cited: 32
Perspective: Cell danger response Biology—The new science that connects environmental health with mitochondria and the rising tide of chronic illness
Robert K. Naviaux
Mitochondrion (2019) Vol. 51, pp. 40-45
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top